- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Aimei Health Technology Co., Ltd Unit (AFJKU)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/08/2026: AFJKU (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -11.58% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.51 - 12.90 | Updated Date 06/5/2025 |
52 Weeks Range 10.51 - 12.90 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 69617552 | Price to Sales(TTM) - |
Enterprise Value 69617552 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders 5.53 | Percent Institutions 0.04 |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Unit
Company Overview
History and Background
Aimei Health Technology Co., Ltd. Unit's founding year, significant milestones, and evolution are not publicly available in detail. As a unit of a larger entity (implied by 'Unit'), its specific history might be integrated with the parent company's narrative. Information on its establishment and early development is limited.
Core Business Areas
- Health Technology Solutions: Focuses on developing and deploying technology-driven solutions for the healthcare industry. This likely includes software, platforms, and services aimed at improving patient care, operational efficiency, and data management within healthcare organizations.
- Digital Health Platforms: Development and provision of digital platforms that facilitate remote patient monitoring, telehealth services, electronic health records (EHR) integration, and patient engagement tools.
- Data Analytics in Healthcare: Leveraging data analytics to extract insights from healthcare data for improved diagnostics, personalized treatment plans, and predictive healthcare models.
Leadership and Structure
Specific leadership details for 'Aimei Health Technology Co., Ltd Unit' are not readily available, as it is likely a division or subsidiary. The organizational structure would typically involve departments focused on research and development, product management, sales and marketing, and customer support, reporting to higher management within the parent organization.
Top Products and Market Share
Key Offerings
- Product Name 1: Aimei Health Platform (Hypothetical Name) - A comprehensive digital health platform offering telehealth, remote monitoring, and patient management. Market share data and specific competitors are not publicly disclosed for this specific unit.
- Product Name 2: AI-Powered Diagnostic Tools (Hypothetical Name) - Software solutions utilizing AI to assist in medical image analysis and disease prediction. Specific market share and competitor information are unavailable.
Market Dynamics
Industry Overview
The digital health and health technology sector is characterized by rapid innovation, increasing demand for remote care solutions, and a growing focus on data-driven healthcare. Key trends include AI integration, personalized medicine, and cybersecurity in healthcare.
Positioning
Aimei Health Technology Co., Ltd. Unit is positioned as a technology provider within the growing digital health market. Its competitive advantages would likely stem from its technological capabilities, potential integration with existing healthcare systems, and its ability to address specific pain points in patient care and operational management. However, specific market share and competitive positioning are not readily available.
Total Addressable Market (TAM)
The total addressable market for digital health solutions is substantial and growing, with projections in the hundreds of billions of dollars globally. Aimei Health Technology Co., Ltd. Unit's position within this TAM depends on its specific product offerings and market penetration, which are not detailed publicly.
Upturn SWOT Analysis
Strengths
- Potential for innovative technology development in the health tech space.
- Focus on addressing growing demand for digital health solutions.
- Possible synergies with a larger parent organization (if applicable).
Weaknesses
- Limited public information on specific products, market share, and financial performance.
- Reliance on the success and strategy of its parent company.
- Brand recognition and market penetration may be limited as a distinct 'Unit'.
Opportunities
- Expansion of telehealth and remote patient monitoring services.
- Growth in AI applications for diagnostics and treatment.
- Increasing adoption of digital health records and interoperability.
- Partnerships with healthcare providers and insurance companies.
Threats
- Intense competition from established tech giants and specialized health tech startups.
- Strict regulatory landscape and data privacy concerns (e.g., HIPAA).
- Rapid technological obsolescence.
- Economic downturns affecting healthcare spending.
Competitors and Market Share
Key Competitors
- Cerner Corporation (Oracle Health) (CERN)
- Epic Systems Corporation (Private)
- Teladoc Health, Inc. (TDOC)
- Philips Healthcare (PHG)
- GE HealthCare Technologies Inc. (GEHC)
Competitive Landscape
Aimei Health Technology Co., Ltd. Unit faces a highly competitive landscape with established players and innovative startups. Its advantages would need to be in niche areas, technological superiority, or cost-effectiveness. Disadvantages include potential lack of brand recognition and scale compared to larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth of 'Aimei Health Technology Co., Ltd Unit' is not independently documented. Growth would be a component of the parent company's overall growth strategy and performance in the health technology sector.
Future Projections: Future projections for Aimei Health Technology Co., Ltd. Unit would be integrated into the parent company's outlook and would depend on its strategic investments, product pipeline, and market adoption within the digital health sector. Specific analyst projections for this unit are not available.
Recent Initiatives: Recent initiatives would likely be aligned with the parent company's strategic goals, potentially involving new product launches, R&D investments in AI or data analytics, or market expansion efforts within the digital health space.
Summary
Aimei Health Technology Co., Ltd. Unit operates in the dynamic digital health sector, with potential strengths in technological innovation and addressing healthcare needs. However, a lack of specific public data makes a definitive assessment challenging. Key weaknesses include limited transparency and potential reliance on a parent company. The company needs to focus on clearly defining its market niche, establishing strong brand recognition, and navigating the complex regulatory environment to thrive amidst intense competition.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry reports on digital health and health technology.
- Information on major competitors in the health tech sector.
- Publicly available financial data for publicly traded competitors.
Disclaimers:
This analysis is based on limited publicly available information for 'Aimei Health Technology Co., Ltd Unit'. Specific financial performance, market share, and detailed product information for this entity are not independently disclosed. The 'Unit' designation suggests it may be part of a larger corporation, and its performance is likely consolidated. Competitor information and market share percentages are indicative and may vary based on specific market segments and reporting periods. This JSON output is for informational purposes only and does not constitute investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Unit
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2023-12-04 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

